-
公开(公告)号:US20140038953A1
公开(公告)日:2014-02-06
申请号:US13979943
申请日:2012-01-20
IPC分类号: C07D487/04 , C07D471/04
CPC分类号: A61K31/519 , A61K31/4709 , A61K31/496 , A61K31/5377 , C07D471/04 , C07D487/04
摘要: The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to reduce circulating levels of ApoB-100 or LDL. These compounds may also be used to treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia; diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism; or diseases, disorders, or syndromes caused by hyperlipidemia.
摘要翻译: 本发明提供BMP信号传导的小分子抑制剂。 这些化合物可用于降低ApoB-100或LDL的循环水平。 这些化合物也可用于治疗或预防获得性或先天性高胆固醇血症或高脂蛋白血症; 与脂质吸收或代谢缺陷相关的疾病,病症或综合征; 或由高脂血症引起的疾病,病症或综合征。